Skip to main content
. Author manuscript; available in PMC: 2018 Oct 2.
Published in final edited form as: JAMA Intern Med. 2014 Dec;174(12):1947–1954. doi: 10.1001/jamainternmed.2014.5302

Figure 2. Treatment Retention and Mean Buprenorphine Dosage for Patients With Prescription Opioid Dependence.

Figure 2.

Patients were assigned to the taper or the maintenance condition. Buprenorphine treatment was administered as a tablet formulation of buprenorphine hydrochloride and naloxone hydrochloride in a 4:1 ratio.